JPH0611331B2 - Method for removing endotoxin from immobilized polymyxin moldings - Google Patents

Method for removing endotoxin from immobilized polymyxin moldings

Info

Publication number
JPH0611331B2
JPH0611331B2 JP59255596A JP25559684A JPH0611331B2 JP H0611331 B2 JPH0611331 B2 JP H0611331B2 JP 59255596 A JP59255596 A JP 59255596A JP 25559684 A JP25559684 A JP 25559684A JP H0611331 B2 JPH0611331 B2 JP H0611331B2
Authority
JP
Japan
Prior art keywords
polymyxin
immobilized
fiber
endotoxin
moldings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59255596A
Other languages
Japanese (ja)
Other versions
JPS61135674A (en
Inventor
定美 斉藤
久敬 小路
和雄 寺本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP59255596A priority Critical patent/JPH0611331B2/en
Publication of JPS61135674A publication Critical patent/JPS61135674A/en
Publication of JPH0611331B2 publication Critical patent/JPH0611331B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、固定化ポリミキシン成形品のエンドトキシン
除去方法に関する。
TECHNICAL FIELD The present invention relates to a method for removing endotoxin from an immobilized polymyxin molded article.

[従来技術] 固定化ポリミキシン成形品を用いて、例えば、血液、水
溶液中のエンドトキシンを解毒しようとする際、固定化
ポリミキシン成形品に製造工程で混入し、付着したエン
ドトキシンが溶離し、本来の目的とは逆に、血液や水溶
液を汚染してしまうという問題があった。
[Prior Art] For example, when an immobilized polymyxin molded product is used to detoxify endotoxin in blood or an aqueous solution, it is mixed with the immobilized polymyxin molded product in the manufacturing process, and the adhered endotoxin elutes. On the contrary, there was a problem of contaminating blood or aqueous solution.

ところが、エンドトキシンの定量法が確立されていなか
ったため、固定化ポリミキシン成形品に付着したエンド
トキシンを積極的に除去しようとする試みは、従来検討
されていなかった。
However, since a method for quantifying endotoxin has not been established, an attempt to positively remove the endotoxin attached to the immobilized polymyxin molded product has not been studied.

例えば、固定化ポリミキシン成形品として、アガロース
にポリミキシンを固定化したものが報告されているが、
積極的なエンドトキシンの除去方法は述べられていな
い。
For example, as an immobilized polymyxin molded article, one in which polymyxin is immobilized on agarose has been reported.
No aggressive endotoxin removal method is mentioned.

[発明が解決しようとする問題点] 本発明は、固定化ポリミキシン成形品に付着したエンド
トキシンを、固定化されたポリミキシンの活性を失うこ
となく、効率よく除去する方法を提供するものである。
[Problems to be Solved by the Invention] The present invention provides a method for efficiently removing endotoxin attached to an immobilized polymyxin molded product without losing the activity of the immobilized polymyxin.

[問題点を解決するための手段] 固定化ポリミキシン成形品をアルカリ溶液と接触させる
ことを特徴とする固定化ポリミキシン成形品からのエン
ドトキシン除去方法。
[Means for Solving Problems] A method for removing endotoxin from an immobilized polymyxin molded article, which comprises contacting the immobilized polymyxin molded article with an alkaline solution.

本発明でいう固定化ポリミキシン成形品とは、ポリミキ
シンを担体に固定化したものである。
The immobilized polymyxin molded product in the present invention is a product in which polymyxin is immobilized on a carrier.

また、ポリミキシンとは、Bacillus Polymyxaにより産
生されるペプチド系抗生物質である。ポリミキシンには
ポリミキシンA、ポリミキシンB、ポリミキシン
、ポリミキシンD、ポリミキシンE、およびポ
リミキシンE等があり、グラム陰性菌に対して抗菌作
用を有するものである。
Polymyxin is a peptide antibiotic produced by Bacillus Polymyxa. Polymyxins include polymyxin A, polymyxin B 1 , polymyxin B 2 , polymyxin D 1 , polymyxin E 1 , polymyxin E 2 and the like, which have an antibacterial action against Gram-negative bacteria.

本発明でいうアルカリ溶液とは、PH9以上、より好ま
しくは、PH12以上の溶液であればよく、特にその種
類などに制限はない。
The alkaline solution referred to in the present invention may be a solution having a pH of 9 or more, more preferably a pH of 12 or more, and there is no particular limitation on its type.

アルカリ溶液の例としては、ナトリウム、カリウム、リ
チウム、セシウム等で代表されるアルカリ金属、カルシ
ウム、バリウム、マグネシウム等で代表されるアルカリ
土類金属などの水酸化物、または、それらの弱酸塩の水
溶液があり、さらにトリメチルベンジルアンモニウムヒ
ドロキサイド等の四級アンモニウム塩の水酸化物があげ
られる。
Examples of the alkaline solution include alkali metal represented by sodium, potassium, lithium, cesium, etc., hydroxide of alkaline earth metal represented by calcium, barium, magnesium etc., or an aqueous solution of a weak acid salt thereof. Further, a hydroxide of a quaternary ammonium salt such as trimethylbenzylammonium hydroxide can be used.

とりわけ、水酸化ナトリウム、水酸化カリウム等が好ま
しい。さらにその濃度は1N以上が好ましい。
Especially, sodium hydroxide, potassium hydroxide and the like are preferable. Further, its concentration is preferably 1N or more.

溶媒としては、水、食塩水、または、有機溶媒等を用い
ることができる。
As the solvent, water, saline, an organic solvent or the like can be used.

また、水と水溶性有機溶媒、例えば水とアルコールなど
の混合溶液が採用される。その時のアルコールの濃度
は、低すぎると効果が小さく、高すぎるとアルカリの溶
解性が低下するので5〜50%、好ましくは10〜30
%の濃度が適用される。
Further, a mixed solution of water and a water-soluble organic solvent, for example, water and alcohol is adopted. If the concentration of alcohol at that time is too low, the effect is small, and if it is too high, the solubility of the alkali decreases, so it is 5 to 50%, preferably 10 to 30.
% Concentrations are applied.

接触手段の例としては、振とう、撹拌あるいはカラムを
通じて連続的に流す方法や浸漬などの手段が採用される
が、中でも溶液の撹拌が好ましく、例えば、超音波撹拌
では成形品の内部まで洗浄が可能であるのでより好まし
い。
As an example of the contact means, shaking, stirring, a method of continuously flowing through a column or a means such as dipping is adopted. Among them, stirring of the solution is preferable, and for example, ultrasonic stirring can wash the inside of the molded product. It is more preferable because it is possible.

溶液の温度は、通常は0℃以上100℃以下の範囲であ
るが、特に室温付近が好ましく適用される。
The temperature of the solution is usually in the range of 0 ° C. or higher and 100 ° C. or lower, but room temperature is preferably applied.

本発明でいう成形品としては、たとえば繊維、中空糸、
膜、ビーズ等があるが、これらに限るものではない。
The molded article referred to in the present invention includes, for example, fibers, hollow fibers,
There are membranes, beads, etc., but not limited to these.

また、その成形品は、耐薬品性、特に耐アルカリ性に優
れていることが必要であり、特に不溶性重合体であるの
が好ましい。例えば不溶性ビニル重合体にポリミキシン
を固定化した成形品が具体例としてあげられる。
Further, the molded product needs to have excellent chemical resistance, particularly alkali resistance, and is preferably an insoluble polymer. For example, a molded product obtained by immobilizing polymyxin on an insoluble vinyl polymer is a specific example.

不溶性重合体の例としては、スチレン、塩化ビニル、ア
クリル酸アミド、アクリロニトリル、無水マレイン酸、
メチクリル酸エステルなどで代表されるモノビニル化合
物の単独重合体、または、ジビニルベンゼン、あるいは
メチレンビスアクリルアミド等で代表されるポリビニル
化合物との共重合体の他、上記モノビニル化合物重合体
成形品をホルムアルデヒドクロルスルホン酸等で架橋処
理したもの等があげられる。
Examples of insoluble polymers include styrene, vinyl chloride, acrylic acid amide, acrylonitrile, maleic anhydride,
A homopolymer of a monovinyl compound represented by methacrylic acid ester or a copolymer with a polyvinyl compound represented by divinylbenzene or methylenebisacrylamide, etc. Examples thereof include those cross-linked with an acid or the like.

これらの不活性重合体にポリミキシン分子を共有結合で
固定化するためには、該重合体にα−ハロゲン化アルキ
ル基、または、カルボン酸エステル基等の官能基が重合
体に直接、または、スペーサーを介して結合しているこ
とが必要であり、このスペーサーの長さは、メチレン基
にして4個以上の長さであることが望ましい。
In order to immobilize a polymyxin molecule to these inactive polymers by covalent bond, a functional group such as α-halogenated alkyl group or carboxylic acid ester group is directly attached to the polymer or a spacer. It is necessary that the spacers are bound via a spacer, and the length of the spacer is preferably 4 or more in terms of methylene group.

[実施例] 実施例1 ポリプロピレン(三井“ノーブレン”J3HG)50部
を島成分とし、ポリスチレン(“スタイロン”666)
46部、ポリプロピレン(住友“ノーブレン”WF−7
27−F)4部の混合物を海成分とする海島型複合繊維
(島数16、単糸繊度2.6デニール、引張強度2.9
g/d、伸度50%、フィラメント数42)50gをN
−メチロール−α−クロルアセトアミド60g、ニトロ
ベンゼン400g、98%硫酸400g、およびびパラ
ホルムアルデヒド0.85gからなる混合溶液中に浸
し、20℃で1時間、反応させた。
Example 1 Example 1 50 parts of polypropylene (Mitsui "Noblen" J3HG) was used as an island component, and polystyrene ("Stylon" 666) was used.
46 parts, polypropylene (Sumitomo "Noblen" WF-7
27-F) Sea-island type composite fiber containing 4 parts of the mixture as a sea component (16 islands, single yarn fineness 2.6 denier, tensile strength 2.9).
g / d, elongation 50%, filament number 42) 50 g N
It was immersed in a mixed solution of 60 g of methylol-α-chloroacetamide, 400 g of nitrobenzene, 400 g of 98% sulfuric acid, and 0.85 g of paraformaldehyde, and reacted at 20 ° C. for 1 hour.

繊維を反応液から取り出し、0℃の氷水5中に投じ
て、反応停止させたのち、水で洗浄し、次に繊維に付着
しているニトロベンゼンをメタノールで抽出除去した。
この繊維(繊維A)を50℃で真空乾燥してクロルアセ
トアミドメチル化繊維71gを得た。
The fiber was taken out of the reaction solution, poured into ice water 5 at 0 ° C. to stop the reaction, washed with water, and then nitrobenzene attached to the fiber was extracted and removed with methanol.
This fiber (fiber A) was vacuum dried at 50 ° C. to obtain 71 g of chloracetamidomethylated fiber.

硫酸ポリミキシンB(シグマ社;8000単位/mg)
4.8gを600mlの水に溶かし、この中に繊維A2
2gを加え5時間振とうした後、酸化マグネシウム1.
5gを添加し、室温で12時間振とうした。
Polymyxin B Sulfate (Sigma; 8000 units / mg)
Dissolve 4.8g in 600ml water and add fiber A2
After adding 2 g and shaking for 5 hours, magnesium oxide 1.
5 g was added and shaken for 12 hours at room temperature.

次にこの繊維を反応母液から取り出し、クロマトカラム
につめて0.1N−塩酸4800mlで洗浄してポリミ
キシン固定化繊維(繊維B)を得た。この洗浄液と反応
母液中のポリミキシン量をミクロビュレット法で測定
し、その量と仕込量の差を繊維に固定化されたポリミキ
シン量とみなした。固定化量は、1.5mg/gであっ
た。
Next, this fiber was taken out of the reaction mother liquor, packed in a chromatographic column, and washed with 4800 ml of 0.1N hydrochloric acid to obtain a polymyxin-immobilized fiber (fiber B). The amount of polymyxin in the washing liquid and the reaction mother liquor was measured by the microburette method, and the difference between the amount and the charged amount was regarded as the amount of polymyxin immobilized on the fiber. The immobilized amount was 1.5 mg / g.

繊維B1gの入った無菌の試験管に、1NNaOH20
%エチルアルコール溶液30mlを入れ、超音波洗浄器
で30分間繊維と溶液を接触させ、液を交換して、再び
超音波洗浄器にかけた。またこの時の溶液の温度は37
℃に調節した。
Add 1N NaOH20 to a sterile test tube containing 1g of fiber B.
30 ml of a% ethyl alcohol solution was added, the fiber and the solution were brought into contact with each other for 30 minutes with an ultrasonic cleaner, the liquid was exchanged, and the ultrasonic cleaner was again applied. The temperature of the solution at this time is 37
The temperature was adjusted to ° C.

エンドトキシン除去後、繊維を無菌のカラムに移し、滅
菌蒸留水を流出水が中性になるまで流した。
After removing the endotoxin, the fiber was transferred to a sterile column, and sterile distilled water was flushed until the outflow water became neutral.

次に無菌のトリス−塩酸バッファー60mlを流し、滅
菌蒸溜水120mlを流した。
Next, 60 ml of sterile Tris-hydrochloric acid buffer was poured, and 120 ml of sterile distilled water was poured.

エンドトキシン除去後、中性化した繊維(繊維C)を滅
菌三角フラスコに入れ、生理食塩水30mlを加え、共
栓をし、37℃で90分間、振とうし、繊維Cの表面に
付着したエンドトキシンを生理食塩水30ml中へ溶離
させた。
After removing the endotoxin, put the neutralized fiber (Fiber C) in a sterilized Erlenmeyer flask, add 30 ml of physiological saline, stopper the mixture, and shake at 90 ° C for 90 minutes. Was eluted into 30 ml of saline.

その結果、繊維C1g当り2.9ngであり、極めて低い
量であった。
As a result, the amount was 2.9 ng / g fiber C, which was an extremely low amount.

比較例 繊維Bを滅菌三角フラスコに入れ、生理食塩水30ml
を加え、共栓をし、37℃で90分間、振とうし、繊維
Bの表面に付着したエンドトキシンを溶離させ、エンド
トキシンを定量した。繊維B1g当り56ngであった。
Comparative Example Fiber B was placed in a sterilized Erlenmeyer flask and 30 ml of physiological saline was added.
Was added, the mixture was stoppered and shaken at 37 ° C. for 90 minutes to elute the endotoxin adhering to the surface of the fiber B, and the endotoxin was quantified. It was 56 ng / g fiber B.

[発明の効果] 固定化ポリミキシン成形品に付着したエンドトキシン
を、該ポリミキシンの活性を失うことなく、効率よく除
去することができる。
[Effect of the Invention] The endotoxin attached to the immobilized polymyxin molded article can be efficiently removed without losing the activity of the polymyxin.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】固定化ポリミキシン成形品をアルカリ溶液
と接触させることを特徴とする固定化ポリミキシン成形
品からのエンドトキシン除去方法。
1. A method for removing endotoxin from an immobilized polymyxin molded article, which comprises contacting the immobilized polymyxin molded article with an alkaline solution.
JP59255596A 1984-12-05 1984-12-05 Method for removing endotoxin from immobilized polymyxin moldings Expired - Lifetime JPH0611331B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59255596A JPH0611331B2 (en) 1984-12-05 1984-12-05 Method for removing endotoxin from immobilized polymyxin moldings

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59255596A JPH0611331B2 (en) 1984-12-05 1984-12-05 Method for removing endotoxin from immobilized polymyxin moldings

Publications (2)

Publication Number Publication Date
JPS61135674A JPS61135674A (en) 1986-06-23
JPH0611331B2 true JPH0611331B2 (en) 1994-02-16

Family

ID=17280917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59255596A Expired - Lifetime JPH0611331B2 (en) 1984-12-05 1984-12-05 Method for removing endotoxin from immobilized polymyxin moldings

Country Status (1)

Country Link
JP (1) JPH0611331B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7471907B2 (en) 2020-05-11 2024-04-22 日機装株式会社 Hollow fiber membrane module

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813519A (en) * 1981-07-16 1983-01-26 Seikagaku Kogyo Co Ltd Endotoxin adsorbent and removing method of endotoxin using the same
JPS5922557A (en) * 1982-07-30 1984-02-04 旭化成株式会社 Endotoxin blood disease treating device

Also Published As

Publication number Publication date
JPS61135674A (en) 1986-06-23

Similar Documents

Publication Publication Date Title
DK170737B1 (en) Perfluorocarbon polymer-based carriers for use in enzyme immobilization and bioaffinity separations
JPH0515438B2 (en)
JPS6230779B2 (en)
JPH06508022A (en) Biomolecule-specific aptamers and production methods
JPS59225064A (en) Carrier for immobilizing physiologically active substance
JPH0738880B2 (en) Endotoxemia treatment
US5204455A (en) Monomethoxytrityl protected oligonucleotides bound to a solid support
JPH0611331B2 (en) Method for removing endotoxin from immobilized polymyxin moldings
JPH0116389B2 (en)
JPH06500781A (en) Poly(fluoroalkyl) sugar reagents and their use for surface modification
US6300486B1 (en) Large scale synthesis of oligonucleotides and their associated analogs
RU2130069C1 (en) Method of virus concentrating
JPS6141608B2 (en)
JPH0364520B2 (en)
JP3177843B2 (en) Method for detecting mutation of nucleic acid base sequence or presence of nucleic acid having specific base sequence
JP2595004B2 (en) Enzyme-immobilizing carrier, its enzyme-immobilizing method and enzyme desorbing method
US6180769B1 (en) Method for linking negatively charged macrobiomolecules to plastics, resulting linked compositions and microtitre plates incorporating same
CN100500840C (en) Penicillin Acylase Crystals and Immobilized Penicillin Acylase
CN112458074B (en) Immobilization method of β-galactosidase
JPS61114734A (en) Method for immobilizing physiologically active substance and fiber therefor
JPS60224637A (en) Carrier for immobilizing physiologically active substance
JPH05305139A (en) Manufacture of physiologically active substance fixed molding
JPS60246766A (en) Blood treating agent
JP2834190B2 (en) Deactivation method of inactivated enzyme
JPS60224618A (en) Carrier for immobilizing physiologically active substance